| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | GCP/IL-8 protein II,MDNCF,IL8/NAP1 form III,IL-8(1-77),Neutrophil-activating factor,GCP/IL-8 protein I,GCP/IL-8 protein VI,Interleukin-8,Chemokine (C-X-C motif) ligand 8,Neutrophil-activating protein 1,Monocyte-derived neutrophil chemotactic factor,(Ser-IL-8)72,MDNCF-b,LYNAP,GCP/IL-8 protein V,IL8/NAP1 form IV,MONAP,IL8/NAP1 form V,IL8/NAP1 form VI,NAP-1,Granulocyte chemotactic protein 1,GCP/IL-8 protein III,IL8/NAP1 form II,IL8,IL-8,CXCL8,IL8/NAP1 form I,(Ala-IL-8)77,Protein 3-10C,GCP/IL-8 protein IV,Emoctakin,GCP-1,C-X-C motif chemokine 8,NAF,T-cell chemotactic factor,MDNCF-c,Monocyte-derived neutrophil-activating peptide,Lymphocyte-derived neutrophil-activating factor |
| Clonality | |
| Form | Liquid |
| Host | |
| Immunogen | E. coli - derived recombinant Human IL8/CXCL8 (Ala23-Ser99). |
| Isotype | |
| Product Type | |
| Reactivity | |
| Storage | |
| Target |
Overview
This antibody is intended for research detection of IL8.
Target
IL8 (GCP/IL-8 protein II)
Target biology
IL8 is a cytokine that participates in immune and inflammatory communication between cells. Cytokine levels and signaling activity are commonly evaluated to understand immune activation states and downstream transcriptional programs.
Expected localization
secreted/extracellular (may vary by cell type and experimental conditions).
Research context
Commonly used in Immunology & Inflammation workflows to study expression changes, pathway state, and cellular localization of IL8.
Compatible workflows
- ELISA
- IHC
- WB
Experimental notes
- Western blot: optimize sample preparation (reducing vs. non‑reducing and denaturing conditions) and titrate antibody to balance sensitivity and background. Apparent molecular weight may vary with isoforms and post‑translational modifications (e.g., glycosylation or phosphorylation).
- IHC: epitope accessibility can depend strongly on fixation and antigen retrieval. Test heat‑induced retrieval buffers (citrate pH ~6 or Tris‑EDTA pH ~9) and adjust retrieval time to improve signal-to-background.
- ELISA: performance is sensitive to coating conditions and blocking chemistry; optimize capture density and blocking reagent to reduce non‑specific binding.
Controls & interpretation
Recommended controls include a positive sample reported to express the target (literature‑validated cell line or tissue), a negative/low‑expression sample when available, and ideally genetic knockdown/knockout or peptide‑blocking approaches to confirm specificity.
Immunogen context
E. coli - derived recombinant Human IL8/CXCL8 (Ala23-Ser99).
Intended use
For research use only. Not for diagnostic procedures.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.